This year we, DIA and CoRE are celebrating the 5th Anniversary of our joint annual meeting on 12-13 July 2022, where industry experts and health authorities from Asia-Pacific meet at the Singapore Annual Meeting. This meeting is in a hybrid format.
The COVID-19 pandemic has ushered an increased speed of healthcare innovations with the hope of effectively managing this public health threat. This meeting offers a neutrally organized forum to discuss lessons learned and better prepare the healthcare system for the next challenges. From 12-13 July, representatives from health authorities and industry leaders meet in person for the first time in two years to foster positive changes in the healthcare environment in the Asia-Pacific.
For this 5th edition the committee and DIA team has put together an agenda with cutting-edge topics which will instigate to open dialogue around:
Current Asia Pacific and global regulatory landscape;
Emerging technology and methodologies in drug development;
Policy, regulatory and infrastructure considerations to fulfil the potential of data use and digital technologies;
Digital health, telemedicine, personalised and integrated care, and the degree of adoption and application in Asia Pacific;
Approaches in Balancing Science and Operations for Better Access;
Adoption of DCTs, the challenges faced and what the future holds for DCT in Asia Pacific region;
Regulatory convergence, reliance and alternative pathways;
Patient centricity and patient-centric health systems that includes emerging technologies, innovations in cancer care, digital health and improved patient access to novel therapies.
Key Speakers:
Raymond CHUA, Deputy Director - Medical Services Health Regulation Group Ministry of Health Singapore
Andrew Pengilley, Senior Medical Advisor, TGA
Ahn Bourcet Nguyen, Director - Market Access, Public Health Policy, Diagnostics (APAC), Abbott
Serena Chan, Executive Director-Clinical Operations, Syneos Health Singapore Pte Ltd.
Ralf ALTENBURGER, Global Head Cell and Gene Therapy and Global Head Pharma Technical Regulatory F. Hoffmann La-Roche Ltd. Basel
Shin-ichi Okudaira, Deputy Review Director - Office of Cellular and Tissue-based Products, PMDA
Fatemeh Razjouyan, Director of Regulatory Policy -International and Harmonization, Global Regulatory Policy, Medtronic
Daniela Caiazza, Senior Director - Clinical Services, Novotech
Yu LIANG -Associate Director Regulatory Affairs APAC, MSD – Singapore
- Jesusa Joyce N. CIRUNAY, RPh Director IV, Center for Drug Regulation and Research, Food and Drug Administration Philippines Civic Drive, Filinvest Corporate City Alabang, Muntinlupa City, Philippines